Needham & Company
-
Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); Poised for Better 2012 After HSIC Entanglement Done
-
Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); Q4 Shortfall, But Outlook Strong
-
Needham & Company Reiterates a 'Buy' on Biolase Technology (BLTI); Great Qtr of Domestic Sales Signals Continued Turnaround
-
Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); The Turnaround Continues; Raising Estimates & Price Target
-
Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); Updating Estimates for 3Q10 Actual Results and Other Recent Developments
